Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-sparing anesthesia for prevention of postoperative nausea and vomiting after thyroid surgery
ChiCTR2300072353Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil and propofol in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Postoperative nausea and vomiting. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300072353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072353.